These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 458631)

  • 21. [Heparin dosage in long-term intravenous administration based on the example of vascular surgery patients].
    Braun V; Homann B; Sperling M
    Anaesthesist; 1986 May; 35(5):291-8. PubMed ID: 3740376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation by constant subcutaneous heparin infusion.
    Parrilla N; Ansell J
    Thromb Haemost; 1982 Feb; 47(1):1-2. PubMed ID: 7071800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P
    Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of duration of infusion on elimination rate of alfentanil].
    Castor G; Altmayer P; Venitz J
    Anaesthesiol Reanim; 1995; 20(4):97-100. PubMed ID: 7575958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of drug action in disease states. XIV. Effect of infusion rate on pentylenetetrazol concentrations in serum, brain and cerebrospinal fluid of rats at onset of convulsions.
    Ramzan IM; Levy G
    J Pharmacol Exp Ther; 1985 Sep; 234(3):624-8. PubMed ID: 3875710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different effects of heparin in males and females.
    Campbell NR; Hull RD; Brant R; Hogan DB; Pineo GF; Raskob GE
    Clin Invest Med; 1998 Apr; 21(2):71-8. PubMed ID: 9562927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The disposition and pharmacokinetics in humans of 5-azacytidine administered intravenously as a bolus or by continuous infusion.
    Israili ZH; Vogler WR; Mingioli ES; Pirkle JL; Smithwick RW; Goldstein JH
    Cancer Res; 1976 Apr; 36(4):1453-61. PubMed ID: 57000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin elimination following continuous infusion during intra-aortic balloon counterpulsation.
    Jacob AS; Steingart RH; Schweger MJ
    Cathet Cardiovasc Diagn; 1985; 11(4):389-92. PubMed ID: 4042156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of heparin after a single intravenous or subcutaneous injection].
    Mombelli G; Schaedelin J; Beck EA
    Schweiz Med Wochenschr; 1977 Jun; 107(23):810-5. PubMed ID: 877532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin kinetics in venous thrombosis and pulmonary embolism.
    Hirsh J; van Aken WG; Gallus AS; Dollery CT; Cade JF; Yung WL
    Circulation; 1976 Apr; 53(4):691-5. PubMed ID: 1253392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin clearance in the newborn.
    McDonald MM; Jacobson LJ; Hay WW; Hathaway WE
    Pediatr Res; 1981 Jul; 15(7):1015-8. PubMed ID: 7254945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of eltanolone following bolus injection and constant rate infusion.
    Parivar K; Wessén A; Widman M; Nilsson A
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):535-49. PubMed ID: 9300349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The disposition of intravenous doxapram in man.
    Clements JA; Robson RH; Prescott LF
    Eur J Clin Pharmacol; 1979; 16(6):411-6. PubMed ID: 527638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of metapramine (19560 RP) in man after infusion and intravenous injection.
    Sumirtapura YC; Leroux Y; Komar AR; Cano JP; Gaillot J
    Eur J Clin Pharmacol; 1983; 25(5):673-7. PubMed ID: 6662165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a saturable mechanism of disappearance of standard heparin in rabbits.
    Boneu B; Caranobe C; Gabaig AM; Dupouy D; Sie P; Buchanan MR; Hirsh J
    Thromb Res; 1987 Jun; 46(6):835-44. PubMed ID: 3629550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic modeling of heparin and its clinical implications.
    McAvoy TJ
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):331-54. PubMed ID: 512841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The kinetics of heparin.
    Estes JW
    Ann N Y Acad Sci; 1971 Jul; 179():187-204. PubMed ID: 5285374
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of tubocurarine administered by combined i.v. bolus and infusion.
    Ramzan MI; Shanks CA; Triggs EJ
    Br J Anaesth; 1980 Sep; 52(9):893-9. PubMed ID: 7437228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of penicillamine in a female mongrel dog.
    Bergstrom RF; Kay RD; Wagner JG
    J Pharmacokinet Biopharm; 1981 Oct; 9(5):603-21. PubMed ID: 7334461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.